Contineum Therapeutics (CTNM) Change in Account Payables (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Change in Account Payables of -$990000.0 for Q2 2026, up 39.78% year-over-year from -$708250.7 in Q2 2025, and down 302.04% quarter-over-quarter from $490000.0 in Q1 2026.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Change in Account Payables (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Change in Account Payables history runs 4 years deep, the most recent figure standing at -$990000.0 for Q2 2026.
- In Q2 2026, Change in Account Payables rose 39.78% year-over-year to -$990000.0; the TTM figure through Jun 2026 stood at -$1.6 million (down 226.65% YoY), while the FY2025 annual figure was -$869000.0, down 176.16% from the prior year.
- Change in Account Payables for Q2 2026 stood at -$990000.0, down from $490000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.8 million in Q1 2025, with the low at -$1.6 million in Q2 2025.
- The 4-year median for Change in Account Payables is $166000.0 (2024), against an average of -$16285.7.
- Peak annual rise in Change in Account Payables reached 2720.0% in 2025, while the deepest fall reached 1067.06% in 2025.
- Contineum Therapeutics' Change in Account Payables stood at -$625000.0 in 2023, then soared by 160.48% to $378000.0 in 2024, then sank by 57.14% to $162000.0 in 2025, then slumped by 711.11% to -$990000.0 in 2026.
- Business Quant data shows CTNM's Change in Account Payables at -$990000.0 in Q2 2026, $490000.0 in Q1 2026, and $162000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Contineum Therapeutics | 628.71 Mn | 628.71 Mn | - | -990,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -990,000.00 |
| Mar 31, 2026 | 490,000.00 |
| Dec 31, 2025 | 162,000.00 |
| Sep 30, 2025 | -1.22 Mn |
| Jun 30, 2025 | -1.64 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 378,000.00 |
| Sep 30, 2024 | 663,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | -625,000.00 |
| Sep 30, 2023 | 656,000.00 |
| Jun 30, 2023 | -313,000.00 |
| Mar 31, 2023 | 282,000.00 |